Compositions and methods for treating or preventing catecholaminergic polymorphic ventricular tachycardia
The present invention features AIP peptide and polynucleotide compositions, methods of using such compositions for the treatment of CPVT, as well as a human induced pluripotent stem cell derived cardiomyocyte model, useful in characterizing agents that modulate myocardial conduction and contraction..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 30. Jan. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
PU WILLIAM [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-01-30, Last update posted on www.tib.eu: 2023-09-25, Last updated: 2023-09-29 |
|---|
| Patentnummer: |
AU2018297171 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA002320398 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA002320398 | ||
| 003 | DE-627 | ||
| 005 | 20240327215450.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA002320398 | ||
| 035 | |a (EPA)AU2018297171 | ||
| 035 | |a (EPA)64950369 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a PU WILLIAM |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Compositions and methods for treating or preventing catecholaminergic polymorphic ventricular tachycardia |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-01-30, Last update posted on www.tib.eu: 2023-09-25, Last updated: 2023-09-29 | ||
| 520 | |a The present invention features AIP peptide and polynucleotide compositions, methods of using such compositions for the treatment of CPVT, as well as a human induced pluripotent stem cell derived cardiomyocyte model, useful in characterizing agents that modulate myocardial conduction and contraction. | ||
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a BEZZERIDES VASSILIOS |4 aut | |
| 700 | 0 | |a ZHANG DONGHUI |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 30. Jan. |
| 773 | 1 | 8 | |g year:2020 |g day:30 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/64950369/publication/AU2018297171A1?q=AU2018297171 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2020 |b 30 |c 01 | ||